Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement.
Publication
, Journal Article
Greenland, JR; Perch, M; Halloran, K; Levine, DJ; Morrell, ED; Reed, A; Shaver, CM; Singer, JP; Sweet, SC; Vos, R; Aryal, S; Avdimiretz, N ...
Published in: J Heart Lung Transplant
February 2026
Duke Scholars
Published In
J Heart Lung Transplant
DOI
EISSN
1557-3117
Publication Date
February 2026
Volume
45
Issue
2
Start / End Page
168 / 171
Location
United States
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Greenland, J. R., Perch, M., Halloran, K., Levine, D. J., Morrell, E. D., Reed, A., … Todd, J. L. (2026). Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement. J Heart Lung Transplant, 45(2), 168–171. https://doi.org/10.1016/j.healun.2025.09.016
Greenland, John R., Michael Perch, Kieran Halloran, Deborah J. Levine, Eric D. Morrell, Anna Reed, Ciara M. Shaver, et al. “Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement.” J Heart Lung Transplant 45, no. 2 (February 2026): 168–71. https://doi.org/10.1016/j.healun.2025.09.016.
Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, et al. Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement. J Heart Lung Transplant. 2026 Feb;45(2):168–71.
Greenland, John R., et al. “Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement.” J Heart Lung Transplant, vol. 45, no. 2, Feb. 2026, pp. 168–71. Pubmed, doi:10.1016/j.healun.2025.09.016.
Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, Shaver CM, Singer JP, Sweet SC, Vos R, Aryal S, Avdimiretz N, Burrows F, Calabrese D, Calabrese F, Campos S, Combs M, de Perrot M, Dellgren G, Diamond JM, Egan T, Ging P, Glidden DV, Goddard M, Jyothula S, Keller M, Kulkarni H, Kwakkel-van Erp JM, Lama V, Marczin N, Martinu T, Neely ML, Palmer SM, Patterson CM, Pavlisko EN, Pham C, Sanchez M, Schultz HHL, Schwerk N, Shah U, Shashaty M, Singer L, Smith P, Snyder LD, Solomon M, Verleden S, Verplancke V, Zeevi A, Todd JL. Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement. J Heart Lung Transplant. 2026 Feb;45(2):168–171.
Published In
J Heart Lung Transplant
DOI
EISSN
1557-3117
Publication Date
February 2026
Volume
45
Issue
2
Start / End Page
168 / 171
Location
United States
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology